SEC Form 4 · accession 0001179022-15-000086

GALECTIN THERAPEUTICS INC · GALT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Mar 12, 2015

Accepted (ET)

Jul 8, 2015 · 4:59 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001133416

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 12, 2015	A	11,112	$0.00	A	103,086	D
Common Stock	Apr 7, 2015	A	1,054	$0.00	A	104,140	D
Common Stock	Apr 8, 2015	A	15,921	$0.00	A	120,061	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Stock Option (right to buy)^F2,F1	$6.48	Apr 8, 2015	D	7,408	D	—	Mar 24, 2016	Common Stock	7,408	D
Stock Option (right to buy)^F2,F3	$7.08	Apr 8, 2015	D	6,780	D	—	Jun 28, 2021	Common Stock	6,780	D
Stock Option (right to buy)^F2,F4	$3.59	Apr 8, 2015	D	10,034	D	—	Mar 28, 2023	Common Stock	10,034	D

F1The option vested quarterly in eight equal installments beginning May 12, 2011.
F2The option was canceled by mutual agreement of the reporting person and Galectin Therapeutics, Inc. The reporting person received 15,921 shares of restricted common stock, reported in Table 1 of this Form 4, as consideration for the cancellation of options granted on March 24, 2011, June 28, 2011 and March 28, 2013.
F3The option vested as to one-eighth of the shares on June 28, 2011 and thereafter quarterly in seven equal installments beginning August 12, 2011.
F4The option vested quarterly in eight equal installments beginning on May 12, 2013.